A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy

Overview of attention for article published in Journal of Neuro-Oncology, March 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

patent: 5 patents

Readers on

mendeley: 75 Mendeley

So far, Altmetric has seen 5 patents that reference this research output.

Ion-sensitive nasal in-situ gel loaded with temozolomide and disulfiram and preparation…

Application CN-114099501-A

China

01 Mar 2022

Uses of dopamine beta-hydroxylase (DBH) inhibitors and serotonin receptor (5-HT…

Grant US-11185542-B2

United States of America

30 Nov 2021

Disulfiram and metal salt staggered oral dosing regimen and staggered-release oral unit…

Grant US-10905661-B2

United States of America

02 Feb 2021

Disulfiram and metal salt staggered oral dosing regimen and staggered-release oral unit…

Grant US-10322096-B2

United States of America

18 Jun 2019

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 1 additional patents.